Here are five things to know.
1. C. auris is a drug-resistant yeast causing infections in healthcare settings around the globe. Some strains of the fungus are resistant to all three classes of antifungal medications. The fungus can cause serious bloodstream and wound infections.
2. The drug-resistant yeast was first identified in Japan in 2009 and spread to the U.K. in 2013.
3. As of July, more than 200 patients have been infected with C. auris at 20 separate National Health Services trusts and independent hospitals, according to the BBC.
4. Large outbreaks occurred at three U.K. hospitals since 2013, but have since ended. During one such outbreak at Royal Brompton Hospital in London, 50 patients were infected from April 2015 to July 2016.
As of July 14, the CDC has identified 98 C. auris infections among U.S. residents and detected colonization with the fungus in 110 patients.
More articles on infection control:
Top 10 infection control stories, Aug. 7-11
Rotavirus vaccinations saved the US at least $1.2B in medical costs, study shows
300+ sickened in Ohio norovirus outbreak
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
